ADVFN Logo ADVFN

Wir konnten keine Ergebnisse für:
Stelle sicher, dass deine Schreibweise korrekt ist oder versuche deine Suche zu erweitern.

Trends

Toplisten

Es scheint, dass du nicht eingeloggt bist.
Klicke auf den Button unten, um dich einzuloggen und deine zuletzt angesehenen Aktien zu sehen.

Hot Features

Registration Strip Icon for charts Registrieren Sie sich für Echtzeit-Charts, Analysetools und Preise.
41,60
0,20
( 0,48% )
Aktualisiert: 09:30:18
Echtzeitdaten

Professionelle Tools für Privatanleger.

Wichtige Statistiken und Details

Current Price
41,60
Gebot
41,00
Fragen
41,60
Volumen
3
41,00 Tagesbereich 41,60
0,00 52-Wochen-Bereich 0,00
Marktkapitalisierung
Handelsende
41,40
Handelsbeginn
41,00
Letzte Trade
1
@
41.6
Letzter Handelszeitpunkt
09:30:18
Finanzvolumen
-
VWAP
-
Durchschnittliches Volumen (3 Mio.)
-
Ausgegebene Aktien
19.785.726
Dividendenrendite
-
Kurs-Gewinn-Verhältnis
6,53
Gewinn pro Aktie (EPS)
6,34
Erlöse
684,6M
Nettogewinn
125,42M

Über Biotest AG

Sektor
Pharmaceutical Preparations
Branche
Pharmaceutical Preparations
Website
Hauptsitz
Dreieich, Deu
Gegründet
1946
Biotest AG is listed in the Pharmaceutical Preparations sector of the Tradegate (DE) with ticker BIO. The last closing price for Biotest was 41,40 €. Over the last year, Biotest shares have traded in a share price range of 0,00 € to 0,00 €.

Biotest currently has 19.785.726 shares in issue. The market capitalisation of Biotest is 819,13 € million. Biotest has a price to earnings ratio (PE ratio) of 6.53.

BIO Neueste Nachrichten

BioAlliance Pharma : Première réunion du Comité d’Experts international sur la mucite orale et la stratégie de dévelop...

Regulatory News : BioAlliance Pharma SA (Paris:BIO) (Euronext Paris - BIO), Société d’innovation dédiée aux produits orphelins en cancérologie et aux produits de spécialité, annonce...

BioAlliance Pharma: Key milestones and consolidated accounts

First semester 2013 Grant of the Marketing Authorization for Sitavig® in the US Strong achievements in clinical trials with Livatag® (phase III) and Validive® (phase II...

BioAlliance Pharma : Disclosure of Total Number of Voting Rights and Number of Shares in the Capital at August 31, 2013

Regulatory News : BioAlliance Pharma (Paris:BIO) : Pursuant to article L.233-8 II of the Code de commerce (the French Commercial Code) and article 223-16 of the Règlement général...

BioAlliance Pharma : Informations relatives au nombre total de droits de vote et d’actions composant le capital au 31 juill...

Regulatory News : BioAlliance Pharma (Paris:BIO) : Conformément à l’article L. 233-8 II du Code de commerce et à l’article 223-16 du Règlement général de l’Autorité des Marchés...

BioAlliance Pharma annonce le vif succès de son augmentation de capital

Montant brut levé : 8,7 millions d’euros ; Opération sursouscrite à hauteur de 155 % ; Exercice de la clause d’extension.

BioAlliance Pharma Expands and Strengthens Its Industrial Property Assets with Two Patent Grants

Regulatory News: BioAlliance Pharma SA (Paris:BIO), an innovative Company dedicated to the development of orphan oncology products and supportive care products, announces it was...

Zeitraum †ÄnderungÄnderung %HandelsbeginnHochNiedrigDurchsch. VolumenVWAP
10000000DE
40000000DE
120000000DE
260000000DE
520000000DE
1560000000DE
2600000000DE

BIO - Frequently Asked Questions (FAQ)

What is the current Biotest share price?
The current share price of Biotest is 41,60 €
How many Biotest shares are in issue?
Biotest has 19.785.726 shares in issue
What is the market cap of Biotest?
The market capitalisation of Biotest is EUR 819,13M
What is the 1 year trading range for Biotest share price?
Biotest has traded in the range of 0,00 € to 0,00 € during the past year
What is the PE ratio of Biotest?
The price to earnings ratio of Biotest is 6,53
What is the cash to sales ratio of Biotest?
The cash to sales ratio of Biotest is 1,2
What is the reporting currency for Biotest?
Biotest reports financial results in EUR
What is the latest annual turnover for Biotest?
The latest annual turnover of Biotest is EUR 684,6M
What is the latest annual profit for Biotest?
The latest annual profit of Biotest is EUR 125,42M
What is the registered address of Biotest?
The registered address for Biotest is LANDSTEINERSTRASSE 5, DREIEICH, 63303
What is the Biotest website address?
The website address for Biotest is www.biotest.de
Which industry sector does Biotest operate in?
Biotest operates in the PHARMACEUTICAL PREPARATIONS sector
  • Volumen
  • % Tops
  • % Flops
SymbolPreisVol.
0RARAPT Therapeutics Inc
1,50 €
(87,50%)
25,94k
NL8Genesis Ai Corp
0,039 €
(45,52%)
208,98k
FWR0Yumy Candy Company Inc the
0,0358 €
(43,20%)
1,79M
E3O1Nexoptic Technology Corp
0,026 €
(40,54%)
2,84k
4XHFreeport Resources Inc
0,021 €
(40,00%)
15,14k
WWTWater Ways Technologies Inc
0,0045 €
(-95,91%)
2,53k
L7C2Windfall Geotek Inc
0,0025 €
(-70,59%)
40k
QP9Atco Mining Inc
0,003 €
(-55,88%)
1,5k
AWY0Percheron Therapeutics Ltd
0,002 €
(-55,56%)
155k
0PV2Moovly Media Inc
0,002 €
(-55,56%)
500
D7GNel ASA
0,2485 €
(-1,23%)
1,81M
DI6Distribuidora Internacional De Alimentacion SA
0,0169 €
(1,20%)
1,81M
FWR0Yumy Candy Company Inc the
0,0358 €
(43,20%)
1,79M
JSISamhallsbyggnadsbolaget Norden AB
0,383 €
(7,61%)
1,79M
RQ0DWave Quantum Inc
7,634 €
(19,96%)
1,15M
Keine Diskussionen Gefunden.
Neuen Thread Erstellen

Kürzlich von Ihnen besucht

Delayed Upgrade Clock